Pharmexa

Pharmexa is a leading biotech company in the field of active immunotherapy and vaccines for the treatment of cancer, serious chronic and infectious diseases. The company has been listed on the Copenhagen Stock Exchange since 2000. The Pharmexa group consists of GemVax AS, a Norwegian subsidiary, developing peptide vaccines for cancer and Pharmexa-Epimmune, a US subsidiary, focusing on T cell epitope-based vaccines for cancer and infectious diseases.Pharmexa's lead programs include a proprietary peptide vaccine targeting telomerase in phase III, a recombinant protein vaccine targeting HER-2 currently in phase II and several vaccine candidates for HIV therapy and prophylaxis currently in phase I. Earlier programs target RANKL, TNF-alpha, malaria, influenza and other promising targets

Contact Details: Medicon Valley, in the Science Park Hørsholm DK-2970 Denmark Tel: 45 45 16 25 25 Fax: 45 45 16 25 00 Email: Info@Pharmexa.com WWW: www.me.dk/

Recent Publications by Pharmexa:
Formulation and Characterization of a Ten-peptide Single-vial Vaccine, EP-2101, Designed to Induce Cytotoxic T-lymphocyte Responses for Cancer Immunotherapy. Effective vaccines that mediate clinical responses in cancer patients may...	3rd April, 2008	Pharmexa-Epimmune Inc., 5820 Nancy Ridge Drive, Suite 100, San Diego, CA	Hum Vaccin. 2007 Nov 11;4(3).
Breaking B-cell tolerance and CTL tolerance in three OVA-transgenic mouse strains expressing different levels of OVA. It is of major importance to overcome the immunological tolerance in...	13th February, 2008	Pharmexa A/S, Kogle Alle 6, Horsholm, Denmark.	Scand J Immunol. 2008 Feb;67(2):113-20. DOI Direct Link
Perspectives on the development of a therapeutic HER-2 cancer vaccine. With good reason, the majority of cancer vaccines tested, or being tested,...	17th January, 2008	Pharmexa A/S, Kogle	Vaccine. 2007 Sep 27;25 Suppl 2:B17-23. Epub 2007 Jun 18. DOI Direct Link
Generation of autoreactive CTL by tumour vaccines containing foreign T helper epitopes. The aim of this study was to evaluate the effect of including a foreign T...	5th May, 2007	Pharmexa A/S, Horsholm, Denmark.	Scand J Immunol. 2007 Mar;65(3):240-8. DOI Direct Link
Alternative protein secretion: the Mam1 ABC transporter supports secretion of M-factor linked GFP in fission yeast. To examine whether the fission yeast Mam1 ABC transporter can be used for...	13th January, 2006	Pharmexa A/S, Kogle	Biochem Biophys Res Commun. 2005 Dec 30;338(4):1853-9. Epub 2005 Nov 2. DOI Direct Link
→View more Pharmexa research publications.

BioNews Results for Pharmexa:
BIOTECH: Biotech development surge continues	North County Times:  Sep 25 2008 9:58AM Matching: pharmexa
Affitech Announces Second Milestone in Roche Antibody Discovery Collaboration	PR Newswire:  Sep 23 2008 11:22AM Matching: pharmexa
Affitech Announces Second Milestone in Roche Antibody Discovery Collaboration	Montana's News Station:  Sep 23 2008 9:50AM Matching: pharmexa
Affitech Announces Second Milestone in Roche Antibody Discovery Collaboration	Twin Cities Business Journal:  Sep 23 2008 8:12AM Matching: pharmexa
Affitech Announces Second Milestone in Roche Antibody Discovery Collaboration	KSLA:  Sep 23 2008 7:39AM Matching: pharmexa
Promote your company here: BioNewsCast - Press Release Distribution	→View more Pharmexa news.

Pharmexa Patents:
US Patent No.	Title
7364741	Peptides of human Papilloma virus for use in human T cell response inducing compositions
7005498	Methods for therapeutic vaccination
7056512	Method for down-regulating GDF-8 activity
7070784	Method for down-regulating GDF-8 activity using immunogenic GDF-8 analogues
7097837	Synthetic vaccine agents
→View more Pharmexa patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 173 times since April 2007, the link to the organisation's website has been followed 23 times

Recent Search Terms used to find this page: Pharmexa | pharmexa | pharmexa | Pharmexa | Pharmexa | f | .

Search for more companies in Hørsholm

Search for more companies in

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Pharmexa